StockData
Erasca, Inc. logo

Erasca, Inc. (ERAS) stock

ERASNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$13.89−1.22 (-8.07%)

Close on Nov 17, 2026Market cap $4.86BP/E –Yield 0.00%

Erasca total assets

Total assets on the balance sheet at the end of each period.

Erasca's total assets was $435.05M at Jun 30, 2026. For fiscal 2025 it was $396.15M, down 21.2% from the year before. The highest annual figure on record is $514.91M in fiscal 2022.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$396.15M-21.2%
FY2024Dec 31, 2024$502.53M+27.1%
FY2023Dec 31, 2023$395.30M-23.2%
FY2022Dec 31, 2022$514.91M+2.7%
FY2021Dec 31, 2021$501.42M+301.7%
FY2020Dec 31, 2020$124.83M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$435.05M-2.3%
Q1 FY2026Mar 31, 2026$461.23M-2.1%
Q4 FY2025Dec 31, 2025$396.15M-21.2%
Q3 FY2025Sep 30, 2025$420.40M-20.5%
Q2 FY2025Jun 30, 2025$445.39M-15.3%
Q1 FY2025Mar 31, 2025$471.24M+27.4%
Q4 FY2024Dec 31, 2024$502.53M+27.1%
Q3 FY2024Sep 30, 2024$528.90M+26.1%
Q2 FY2024Jun 30, 2024$525.74M+19.3%
Q1 FY2024Mar 31, 2024$370.02M-20.9%
Q4 FY2023Dec 31, 2023$395.30M-23.2%
Q3 FY2023Sep 30, 2023$419.41M-6.1%
Q2 FY2023Jun 30, 2023$440.66M-0.9%
Q1 FY2023Mar 31, 2023$467.54M-1.7%
Q4 FY2022Dec 31, 2022$514.91M+2.7%
Q3 FY2022Sep 30, 2022$446.43M-14.5%
Q2 FY2022Jun 30, 2022$444.82M+111.4%
Q1 FY2022Mar 31, 2022$475.47M+280.9%
Q4 FY2021Dec 31, 2021$501.42M–
Q3 FY2021Sep 30, 2021$521.95M–
Q2 FY2021Jun 30, 2021$210.38M–
Q4 FY2020Dec 31, 2020$124.83M–

More Erasca figures

See a number that looks wrong?